194 related articles for article (PubMed ID: 30055660)
1. Disclosure of amyloid positron emission tomography results to individuals without dementia: a systematic review.
de Wilde A; van Buchem MM; Otten RHJ; Bouwman F; Stephens A; Barkhof F; Scheltens P; van der Flier WM
Alzheimers Res Ther; 2018 Jul; 10(1):72. PubMed ID: 30055660
[TBL] [Abstract][Full Text] [Related]
2. Amnestic MCI patients' experiences after disclosure of their amyloid PET result in a research context.
Vanderschaeghe G; Schaeverbeke J; Bruffaerts R; Vandenberghe R; Dierickx K
Alzheimers Res Ther; 2017 Dec; 9(1):92. PubMed ID: 29197423
[TBL] [Abstract][Full Text] [Related]
3. Analysis of Psychological Symptoms Following Disclosure of Amyloid-Positron Emission Tomography Imaging Results to Adults With Subjective Cognitive Decline.
Caprioglio C; Ribaldi F; Visser LNC; Minguillon C; Collij LE; Grau-Rivera O; Zeyen P; Molinuevo JL; Gispert JD; Garibotto V; Moro C; Walker Z; Edison P; Demonet JF; Barkhof F; Scheltens P; Alves IL; Gismondi R; Farrar G; Stephens AW; Jessen F; Frisoni GB; Altomare D;
JAMA Netw Open; 2023 Jan; 6(1):e2250921. PubMed ID: 36637820
[TBL] [Abstract][Full Text] [Related]
4. Disclosure of amyloid PET scan results: A systematic review.
Kim H; Lingler JH
Prog Mol Biol Transl Sci; 2019; 165():401-414. PubMed ID: 31481171
[TBL] [Abstract][Full Text] [Related]
5. "And Does That Necessarily Mean Absolutely Alzheimer's?" An Analysis of Questions Raised Following Amyloid PET Results Disclosure.
Kim JE; Tamres LK; Orbell SL; Cheng RZ; Klunk WE; Aizenstein HJ; Butters MA; McDade E; Lingler JH
Am J Geriatr Psychiatry; 2024 Jan; 32(1):45-54. PubMed ID: 37634955
[TBL] [Abstract][Full Text] [Related]
6. Development of a Standardized Approach to Disclosing Amyloid Imaging Research Results in Mild Cognitive Impairment.
Lingler JH; Butters MA; Gentry AL; Hu L; Hunsaker AE; Klunk WE; Mattos MK; Parker LS; Roberts JS; Schulz R
J Alzheimers Dis; 2016 Mar; 52(1):17-24. PubMed ID: 27060950
[TBL] [Abstract][Full Text] [Related]
7. Safety of disclosing amyloid status in cognitively normal older adults.
Burns JM; Johnson DK; Liebmann EP; Bothwell RJ; Morris JK; Vidoni ED
Alzheimers Dement; 2017 Sep; 13(9):1024-1030. PubMed ID: 28263740
[TBL] [Abstract][Full Text] [Related]
8. A randomized controlled trial of amyloid positron emission tomography results disclosure in mild cognitive impairment.
Lingler JH; Sereika SM; Butters MA; Cohen AD; Klunk WE; Knox ML; McDade E; Nadkarni NK; Roberts JS; Tamres LK; Lopez OL
Alzheimers Dement; 2020 Sep; 16(9):1330-1337. PubMed ID: 32588971
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of Amyloid Positron Emission Tomographic Positivity in Poststroke Mild Cognitive Impairment.
Wollenweber FA; Därr S; Müller C; Duering M; Buerger K; Zietemann V; Malik R; Brendel M; Ertl-Wagner B; Bartenstein P; Rominger A; Dichgans M
Stroke; 2016 Oct; 47(10):2645-8. PubMed ID: 27539301
[TBL] [Abstract][Full Text] [Related]
10. Added value and limitations of amyloid-PET imaging: review and analysis of selected cases of mild cognitive impairment and dementia.
Weidman DA; Zamrini E; Sabbagh MN; Jacobson S; Burke A; Belden C; Powell J; Bhalla N; Roontiva A; Kuang X; Luo J; Chen K; Riggs G; Burke W
Neurocase; 2017 Feb; 23(1):41-51. PubMed ID: 28376695
[TBL] [Abstract][Full Text] [Related]
11. Disclosure of positron emission tomography amyloid imaging results: A preliminary study of safety and tolerability.
Lim YY; Maruff P; Getter C; Snyder PJ
Alzheimers Dement; 2016 Apr; 12(4):454-8. PubMed ID: 26750717
[TBL] [Abstract][Full Text] [Related]
12. Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition.
Pontecorvo MJ; Devous MD; Navitsky M; Lu M; Salloway S; Schaerf FW; Jennings D; Arora AK; McGeehan A; Lim NC; Xiong H; Joshi AD; Siderowf A; Mintun MA;
Brain; 2017 Mar; 140(3):748-763. PubMed ID: 28077397
[TBL] [Abstract][Full Text] [Related]
13. Identifying best practices for disclosure of amyloid imaging results: A randomized controlled trial.
Fruijtier AD; van der Schaar J; van Maurik IS; Zwan MD; Scheltens P; Bouwman F; Pijnenburg YAL; van Berckel BNM; Ebenau J; van der Flier WM; Smets EMA; Visser LNC
Alzheimers Dement; 2023 Jan; 19(1):285-295. PubMed ID: 35366050
[TBL] [Abstract][Full Text] [Related]
14. Testing and disclosures related to amyloid imaging and Alzheimer's disease: Common questions and fact sheet summary.
Rabinovici GD; Karlawish J; Knopman D; Snyder HM; Sperling R; Carrillo MC
Alzheimers Dement; 2016 Apr; 12(4):510-5. PubMed ID: 27103054
[TBL] [Abstract][Full Text] [Related]
15. Cognitively unimpaired adults' reactions to disclosure of amyloid PET scan results.
Largent EA; Harkins K; van Dyck CH; Hachey S; Sankar P; Karlawish J
PLoS One; 2020; 15(2):e0229137. PubMed ID: 32053667
[TBL] [Abstract][Full Text] [Related]
16. Stakeholders' Views on Early Diagnosis for Alzheimer's Disease, Clinical Trial Participation and Amyloid PET Disclosure: A Focus Group Study.
Vanderschaeghe G; Vandenberghe R; Dierickx K
J Bioeth Inq; 2019 Mar; 16(1):45-59. PubMed ID: 30868358
[TBL] [Abstract][Full Text] [Related]
17. Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer's disease: a voxelwise PiB-PET longitudinal study.
Villain N; Chételat G; Grassiot B; Bourgeat P; Jones G; Ellis KA; Ames D; Martins RN; Eustache F; Salvado O; Masters CL; Rowe CC; Villemagne VL;
Brain; 2012 Jul; 135(Pt 7):2126-39. PubMed ID: 22628162
[TBL] [Abstract][Full Text] [Related]
18. Psychological, behavioral and social effects of disclosing Alzheimer's disease biomarkers to research participants: a systematic review.
Bemelmans SA; Tromp K; Bunnik EM; Milne RJ; Badger S; Brayne C; Schermer MH; Richard E
Alzheimers Res Ther; 2016 Nov; 8(1):46. PubMed ID: 27832826
[TBL] [Abstract][Full Text] [Related]
19. A Pragmatic, Investigator-Driven Process for Disclosure of Amyloid PET Scan Results to ADNI-4 Research Participants.
Erickson CM; Karlawish J; Grill JD; Harkins K; Landau SM; Rivera-Mindt MG; Okonkwo O; Petersen RC; Aisen PS; Weiner MW; Largent EA
J Prev Alzheimers Dis; 2024; 11(2):294-302. PubMed ID: 38374735
[TBL] [Abstract][Full Text] [Related]
20. 18F-FDG PET for Prediction of Conversion to Alzheimer's Disease Dementia in People with Mild Cognitive Impairment: An Updated Systematic Review of Test Accuracy.
Smailagic N; Lafortune L; Kelly S; Hyde C; Brayne C
J Alzheimers Dis; 2018; 64(4):1175-1194. PubMed ID: 30010119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
